ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,583Medicare Part D Prescriptions Filled, Including Refills

Rank: 226 out of 939

$581K Total Retail Price of All Prescriptions

Rank: 188 out of 939

513 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 513 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 513 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 7,234 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
SIMVASTATIN 350 280 1 2
LEVOTHYROXINE SODIUM 310 256 2 4
AMLODIPINE BESYLATE 310 233 2 6
OMEPRAZOLE 306 213 4 5
METFORMIN HCL 305 191 5 8
POTASSIUM CHLORIDE 297 229 6 9
FUROSEMIDE 279 197 7 7
HYDROCODONE-ACETAMINOPHEN 264 120 S3 8 1
LISINOPRIL 243 189 9 3
CITALOPRAM HBR 198 113 10 15
WARFARIN SODIUM 190 92 11 17
ZOLPIDEM TARTRATE 186 110 12 20
HYDROCHLOROTHIAZIDE 182 110 13 12
MELOXICAM 153 142 14 14
AZITHROMYCIN 144 97 15 32
NEXIUM 133 79 16 18
ATORVASTATIN CALCIUM 130 98 17 22
DONEPEZIL HCL 121 121 18 30
SERTRALINE HCL 114 69 19 24
TRAMADOL HCL 104 63 20 16
DIOVAN HCT 98 74 21 74
METOPROLOL TARTRATE 96 77 22 10
CLONIDINE HCL 94 35 23 39
METHYLPREDNISOLONE 93 63 24 118
DIOVAN 92 74 25 50
DIVALPROEX SODIUM 90 46 26 95
METOPROLOL SUCCINATE 90 66 26 21
GABAPENTIN 89 45 28 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 87 81 29 23
TAMSULOSIN HCL 80 80 30 27
CLOPIDOGREL 78 61 31 28
PHENYTOIN SODIUM EXTENDED 77 25 32 99
GLIMEPIRIDE 71 51 33 37
RISPERIDONE 68 57 34 82
BENAZEPRIL HCL 67 64 35 87
ALLOPURINOL 66 45 36 31
QUETIAPINE FUMARATE 61 35 37 69
PLAVIX 59 45 38 48
TRIAMTERENE-HCTZ 59 52 38 33
LEVOFLOXACIN 59 40 38 86
DIGOXIN 58 50 41 45
PREMARIN 56 45 R 42 111
NAMENDA 54 54 43 49
CRESTOR 54 39 43 34
HALOPERIDOL 53 33 45 169
OXYBUTYNIN CHLORIDE ER 53 35 45 167
CEFUROXIME 52 36 47 166
RANITIDINE HCL 50 34 48 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 29, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.